Notify me when Ikarian Capital, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 116 | $441M | +$255M | -$209M | +$46M | ABVX, IONS, CDTX, MAZE, PTCT | 13F-HR | 11/14/2025, 04:10 PM |
| Q2 2025 | 103 | $301M | +$101M | -$116M | -$15.1M | CDTX, ALNY, INSM, VRNA, CRNX | 13F-HR | 8/14/2025, 04:26 PM |
| Q1 2025 | 116 | $307M | +$114M | -$94.4M | +$19.5M | TARS, CRNX, SPY, SRPT, BPMC | 13F-HR | 5/15/2025, 04:11 PM |
| Q4 2024 | 122 | $350M | +$130M | -$100M | +$29.7M | TARS, CRNX, SRRK, BPMC, FBRX | 13F-HR | 2/14/2025, 04:13 PM |
| Q3 2024 | 96 | $317M | +$114M | -$125M | -$10.9M | TARS, CRNX, ELVN, RCUS, VRDN | 13F-HR | 11/14/2024, 04:14 PM |
| Q2 2024 | 85 | $317M | +$89.4M | -$75.2M | +$14.2M | SRPT, CRNX, TARS, SLNO, CRBP | 13F-HR | 8/14/2024, 04:13 PM |
| Q1 2024 | 80 | $367M | +$129M | -$203M | -$73.7M | CRNX, TARS, SLNO, CRBP, SRPT | Restatement | 5/16/2024, 07:00 PM |
| Q4 2023 | 76 | $365M | +$163M | -$109M | +$54M | ARGX, CRNX, SLNO, XHB, BBIO | 13F-HR | 2/14/2024, 04:28 PM |
| Q3 2023 | 113 | $651M | SPY, SRPT, QQQ, XBI, SLRN | 13F-HR | 11/14/2023, 04:19 PM | |||
| Q2 2023 | 164 | $627M | +$433M | -$234M | +$200M | SLRN, ARGX, BBIO, BMEA, TGTX | 13F-HR | 8/14/2023, 09:46 AM |
| Q1 2023 | 114 | $439M | +$296M | -$76.8M | +$219M | SRPT, SRPT, ITCI, RXDX, IMVT | 13F-HR | 5/15/2023, 09:57 AM |
| Q4 2022 | 84 | $414M | +$194M | -$88.2M | +$105M | MDGL, RXDX, IMVT, KRYS, PCVX | 13F-HR | 2/14/2023, 03:26 PM |
| Q3 2022 | 99 | $501M | +$281M | -$104M | +$176M | RLMD, RLMD, SPY, SGEN, BIIB | 13F-HR | 11/14/2022, 03:05 PM |
| Q2 2022 | 130 | $546M | +$251M | -$74.5M | +$177M | ALNY, XBI, AMGN, BIIB, AXSM | 13F-HR | 8/12/2022, 04:24 PM |
| Q1 2022 | 185 | $757M | +$402M | -$73.2M | +$329M | XBI, NBIX, BMRN, AMGN, BIIB | 13F-HR | 5/13/2022, 04:05 PM |
| Q4 2021 | 180 | $669M | +$142M | -$152M | -$10.6M | XBI, BCYC, SRPT, ALNY, HZNP | 13F-HR | 2/14/2022, 08:46 AM |
| Q3 2021 | 140 | $433M | +$125M | -$203M | -$77.4M | BCYC, GOSS, CLDX, CABA, XFOR | 13F-HR | 11/15/2021, 08:41 AM |
| Q2 2021 | 150 | $556M | +$155M | -$247M | -$92.3M | BIIB, CRSP, XFOR, TCON, ALEC | Restatement | 8/18/2021, 01:39 PM |
| Q1 2021 | 175 | $668M | +$308M | -$224M | +$84.1M | LLY, XFOR, TCON, MGNX, GLPG | Restatement | 8/18/2021, 01:35 PM |
| Q4 2020 | 226 | $2.27B | +$1.2B | -$195M | +$1B | MRNA, SRPT, XBI, BIIB, SPY | 13F-HR | 2/12/2021, 02:57 PM |
| Q3 2020 | 166 | $1.37B | +$861M | -$322M | +$540M | XBI, MRTX, MRNA, SRPT, SPY | 13F-HR | 11/16/2020, 08:26 AM |
| Q2 2020 | 164 | $1.26B | +$603M | -$350M | +$253M | SPY, BPMC, QQQ, CCXI, ARGX | 13F-HR | 8/14/2020, 09:20 AM |
| Q1 2020 | 150 | $1.33B | +$1.14B | -$99.2M | +$1.04B | SPY, TLT, SPY, REGN, BIIB | 13F-HR | 5/15/2020, 08:22 AM |
| Q4 2019 | 112 | $617M | ICPT, XBI, GILD, ITCI, IBB | 13F-HR | 1/31/2020, 09:13 AM |